Welcome to LookChem.com Sign In|Join Free
  • or
2-Benzofurancarboxamidine is an organic compound with the chemical formula C8H7N3O. It is a derivative of benzofuran, which is a heterocyclic aromatic compound consisting of a benzene ring fused to a furan ring. The amide group (-CONH2) is attached to the benzofuran structure, making it a carboxamide. 2-Benzofurancarboxamidine is known for its potential applications in the synthesis of various pharmaceuticals and agrochemicals due to its unique chemical properties. It is also used as an intermediate in the preparation of other benzofuran-based compounds. The compound is typically synthesized through various chemical reactions, such as the condensation of o-aminophenol with aldehydes or ketones, followed by cyclization. 2-Benzofurancarboxamidine is an important building block in the development of new molecules with potential therapeutic or pesticidal properties.

72583-87-0

Post Buying Request

72583-87-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

72583-87-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 72583-87-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,2,5,8 and 3 respectively; the second part has 2 digits, 8 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 72583-87:
(7*7)+(6*2)+(5*5)+(4*8)+(3*3)+(2*8)+(1*7)=150
150 % 10 = 0
So 72583-87-0 is a valid CAS Registry Number.
InChI:InChI=1/C9H8N2O/c10-9(11)8-5-6-3-1-2-4-7(6)12-8/h1-5H,(H3,10,11)

72583-87-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-benzofuran-2-carboximidamide

1.2 Other means of identification

Product number -
Other names 2-Benzofurancarboxamidine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:72583-87-0 SDS

72583-87-0Downstream Products

72583-87-0Relevant academic research and scientific papers

ARYL HYDROCARBON RECEPTOR (AHR) ACTIVATOR COMPOUNDS AS CANCER THERAPEUTICS

-

Page/Page column 78, (2020/06/05)

The present disclosure relates to compositions and methods for the diagnosis and treatment or prevention of cancers, particularly cancers that exhibit elevated expression of FOXA1 and/or FOXA1 gene targets, such as certain breast, liver and/or prostate cancers, including luminal and/or ER-positive forms of breast cancer. Three previously identified adenosine receptor antagonists, CGS-15943, MRS-1220 and SCH-58261, as well as furan ring moiety-possessing derivatives of CGS-15943 are specifically provided for killing cancer cells in a manner that appears to involve activation of the aryl hydrocarbon receptor (AHR) by such compounds. The instant disclosure therefore provides for selecting and/or administering CGS-15943, MRS-1220, SCH-58261 and/or a furan-possessing derivative of CGS-15943, MRS-1220 and/or SCH-58261 as a therapeutic agent to target a cancer cell and/or subject having or at risk of developing a cancer. Methods and compositions for therapies that include such compounds are also provided

SUBSTITUTED PYRAZOLE COMPOUNDS

-

Page/Page column 76; 77, (2009/01/24)

Disclosed are protein kinase inhibitors, compositions comprising such inhibitors, and methods of use thereof. More particularly, disclosed are inhibitors of Aurora A (Aurora-2) protein kinase. Also disclosed are methods of treating diseases associated with protein kinases, especially diseases associated with Aurora-2, such as cancer.

Pyridine and pyrimidine derivatives

-

, (2008/06/13)

The present invention provides compounds of formula (I) wherein R1, R2, R3, R4 and X are as defined in the specification, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment

METHOD OF TREATING DISEASES OF THE CNS

-

, (2008/06/13)

The invention is concerned with the use of compounds of the general formula STR1 wherein R 1-R 4 signify hydrogen, halogen, lower-alkyl, lower-alkoxy, aryl, benzyloxy, lower-alkoxy-lower-alkyl, lower-alkyl-sulphanyl, lower-alkyl-sulphanyl-lower-alkyl or R

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 72583-87-0